Latest / The Dales Report | Trade to Black
Cannabis Uplisting May Not Need Congress | TDR Cannabis in 5
In our latest TDR Cannabis in Five presented by Flowhub, host Shadd Dales breaks down one of the biggest questions now circulating throughout the U.S. cannabis industry:Could major cannabis companies eventually uplist to the NYSE and Nasdaq without Congress ever passing SAFE Banking?For years, investors believed federal legislation was the only path toward institutional access, banking reform, and major exchange listings for U.S. cannabis operators. But after medical cannabis officially moved to Schedule III earlier this year, the conversation has started changing fast.Shadd explains how…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.